Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Etsuhijika-jutsuto is a traditional Japanese Kampo medicine, derived from the classical Chinese formula Yue-Bi-Jia-Zhu-Tang, primarily indicated for inflammatory conditions associated with edema and fluid retention. It is a multi-component herbal preparation consisting of six botanical and mineral ingredients: *Ephedra* herb, *Gypsum*, *Atractylodes* rhizome, *Jujube*, *Licorice*, and *Ginger*. In Japan, it is standardized as an extract and widely prescribed for the treatment of acute and chronic nephritis, nephrotic syndrome, arthritis, and exudative skin diseases such as eczema and dermatitis. The formula exerts its therapeutic effects through anti-inflammatory, anti-allergic, and diuretic activities. Pharmacologically, it has been shown to inhibit the production of pro-inflammatory cytokines like TNF-alpha and IL-6, while its ephedrine alkaloids activate adrenergic pathways to facilitate the removal of excess fluid and reduce tissue swelling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on etsuhijika-jutsuto.